143 related articles for article (PubMed ID: 2199032)
21. Enzyme regulatory site-directed drugs. MOdulation of thymidine triphosphate inhibition of thymidine kinase by 5'-amino-5'-deoxythymidine.
Fischer PH; Baxter D
Mol Pharmacol; 1982 Sep; 22(2):231-4. PubMed ID: 7144727
[TBL] [Abstract][Full Text] [Related]
22. Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicity.
Pressacco J; Mitrovski B; Hedley DW; Tsang R; Erlichman C
Biochem Pharmacol; 1995 Jun; 50(1):55-60. PubMed ID: 7605345
[TBL] [Abstract][Full Text] [Related]
23. Perturbation of thymidine kinase regulation: a novel chemotherapeutic approach.
Fischer PH; Vazquez-Padua MA; Reznikoff CA
Adv Enzyme Regul; 1986; 25():21-34. PubMed ID: 3812083
[TBL] [Abstract][Full Text] [Related]
24. Ataxia telangiectasia cells exhibit the same radiosensitization response by incorporation of BrdUrd or IdUrd as do normal human cells.
Raaphorst GP; Azzam EI; Vadasz JA
Radiat Res; 1985 Sep; 103(3):455-60. PubMed ID: 4034938
[TBL] [Abstract][Full Text] [Related]
25. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation.
Raaphorst GP; Vadasz JA; Azzam EI
Radiat Res; 1984 Apr; 98(1):167-75. PubMed ID: 6718691
[TBL] [Abstract][Full Text] [Related]
26. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
27. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
[TBL] [Abstract][Full Text] [Related]
28. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines.
Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J
Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685
[TBL] [Abstract][Full Text] [Related]
29. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
30. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
[TBL] [Abstract][Full Text] [Related]
31. Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.
Benson AB; Trump DL; Cummings KB; Fischer PH
Biochem Pharmacol; 1985 Nov; 34(21):3925-31. PubMed ID: 2933042
[TBL] [Abstract][Full Text] [Related]
32. Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.
Coucke PA; Cottin E; Azria D; Martineau P; Adamer F; Decosterd LA; Buchegger F; Do HP
Eur J Cancer; 2004 Jul; 40(10):1572-80. PubMed ID: 15196542
[TBL] [Abstract][Full Text] [Related]
33. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
[TBL] [Abstract][Full Text] [Related]
34. Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1992; 22(3):499-503. PubMed ID: 1735687
[TBL] [Abstract][Full Text] [Related]
35. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic interactions of 5-fluorouracil and nucleoside analogues in vitro.
Li YX; Coucke PA; Paschoud N; Mirimanoff RO
Anticancer Res; 1997; 17(1A):21-7. PubMed ID: 9066626
[TBL] [Abstract][Full Text] [Related]
37. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity analysis of antagonism of the feedback inhibition of thymidine kinase.
Fischer PH; Fang TT; Lin TS; Hampton A; Bruggink J
Biochem Pharmacol; 1988 Apr; 37(7):1293-8. PubMed ID: 3355601
[TBL] [Abstract][Full Text] [Related]
40. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]